News + Filings Transactions Holdings
All 13F 13D/G Other
|
STAFFORD JOHN S III
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/20/2022 |
SC 13D/A
| STAFFORD JOHN S III reports a 21.8% stake in Aware, Inc. |
06/10/2020 |
SC 13D/A
| STAFFORD JOHN S III reports a 1% stake in Xencor, Inc. |
06/03/2020 |
SC 13D/A
| STAFFORD JOHN S III reports a 5.1% stake in Xencor, Inc. |
05/20/2020 |
SC 13D/A
| STAFFORD JOHN S III reports a 6.2% stake in Xencor, Inc. |
05/12/2020 |
SC 13D/A
| STAFFORD JOHN S III reports a 7.2% stake in Xencor, Inc. |
05/01/2020 |
SC 13D/A
| STAFFORD JOHN S III reports a 8.8% stake in Xencor, Inc. |
04/08/2020 |
SC 13D/A
| STAFFORD JOHN S III reports a 9.9% stake in Xencor, Inc. |
12/27/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/13/2019 |
SC 13D/A
| STAFFORD JOHN S III reports a 4.8% stake in Avid Bioservices, Inc. |
11/22/2019 |
SC 13D/A
| STAFFORD JOHN S III reports a 5.9% stake in Avid Bioservices, Inc. |
02/14/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
04/17/2018 |
SC 13D/A
| STAFFORD JOHN S III reports a 7% stake in Avid Bioservices, Inc. |
04/17/2018 |
SC 13D/A
| STAFFORD JOHN S III reports a 4.2% stake in §240. Avid Bioservices, Inc. |
04/09/2018 |
SC 13D/A
| STAFFORD JOHN S III reports a 6.1% stake in §240. Avid Bioservices, Inc. |
04/06/2018 |
SC 13D/A
| STAFFORD JOHN S III reports a 6.1% stake in §240. Avid Bioservices, Inc. |
02/20/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/08/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
11/28/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
11/28/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
10/27/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
10/27/2017 |
SC 13D/A
| STAFFORD JOHN S III reports a 7.3% stake in Peregrine Pharmaceuticals, Inc. |
10/17/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
10/17/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
10/11/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
10/11/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/14/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/14/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
06/29/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
02/14/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
|
|